Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study).
Giommoni E, Maiello E, Vaccaro V, Rondini E, Vivaldi C, Tortora G, Toppo L, Giordano G, Latiano TP, Lamperini C, Pillozzi S, Boni L, Antonuzzo L, Di Costanzo F.
Giommoni E, et al. Among authors: toppo l.
Curr Oncol. 2021 May 8;28(3):1761-1772. doi: 10.3390/curroncol28030164.
Curr Oncol. 2021.
PMID: 34066784
Free PMC article.
Clinical Trial.